Business Description
Talphera Inc. is a California-based pharmaceutical company focused on treatments used under direct medical supervision. Its leading program, Niyad, is a specialized formulation designed to prevent blood clotting during procedures that route blood outside the body. The company is also working on additional treatments targeting serious conditions such as viral infections, respiratory failure, and abnormal clotting disorders. Originally founded in 2005 as AcelRx Pharmaceuticals, it adopted its current name in early 2024.
